Trial intelligence / Profile preview

Dexamethasone as adjuvant for peripheral nerve blockade in healthy volunteers

2018-001221-98Phase 2Completed

Sponsor
Medical University of Vienna
Start
May 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, triple-blind trial of dexamethasone and ropivacaine (3 arms), sponsored by Medical University of Vienna. Primary endpoints: Duration of sensory nerve blockade, Sensory onset time and 2 more. Started May 2018; status: completed.

02

Drugs

dexamethasoneropivacaine

Beyond the preview

Go deeper on 2018-001221-98.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-001221-98.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call